Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dermatology
    • Combo helps achieve...

    Combo helps achieve faster skin clearance in rosacea patients

    Written by Medha Baranwal Baranwal Published On 2019-07-01T19:20:38+05:30  |  Updated On 1 July 2019 7:20 PM IST
    Combo helps achieve faster skin clearance in rosacea patients

    New Delhi: Addition of 40 mg doxycycline modified-release capsules (DMR) to daily ivermectin 1% cream produces faster responses and increases satisfaction in patients with severe rosacea compared to using 1% ivermectin alone, finds a recent study published in the Journal of the American Academy of Dermatology.


    Rosacea, also called acne rosacea, is a common skin condition that causes redness and often small, red, pus-filled bumps on the face. For patients with moderate to severe rosacea, combination therapy with oral and topical agents has become a common treatment option. Combination therapy might be preferable to monotherapies in simultaneously treating different rosacea features. However, there is a lack of data on combination therapies for rosacea treatment.


    Martin Schaller, from Tübingen University Hospital in Germany, and colleagues evaluated the efficacy and safety of combining ivermectin 1% cream (IVM) and doxycycline 40 mg modified-release capsules (DMR) versus IVM and placebo (PBO) for treatment of severe rosacea.


    For the purpose, they conducted a 12-week multicenter, randomized comparative trial involving adults with severe rosacea, 273 participants were randomly assigned to receive o IVM and DMR (combination arm) and IVM and placebo (monotherapy).

    Also Read: Coffee reduces incidence of rosacea in women

    Key findings of the study include:




    • IVM and DMR exhibited superior efficacy in reducing inflammatory lesions compared with monotherapy (−80.3 versus −73.6 percent) and in the Investigator's Global Assessment (IGA) score.

    • As of week 4, combination therapy had a faster onset of action; at week 12, significantly more patients achieved IGA 0 (11.9 versus 5.1 percent) and 100 percent lesion reduction (17.8 versus 7.2 percent) with combination therapy.

    • The Clinician's Erythema Assessment score, stinging/burning, flushing episodes, Dermatology Life Quality Index, and ocular signs/symptoms were reduced with both treatments, and both treatments were well-tolerated.


    Also Read: Ginkgo seed extracts may be new herbal treatment of Acne

    "Our study results suggest that the combination therapy of IVM and DMR when followed with a proper skin care regime improve treatment results in rosacea patients. We observed a faster onset of visible improvement, greater efficacy, a reduction in flushing episodes, and a decrease in facial stinging and burning following the combo treatment. This offers the opportunity to reach skin clearance in more patients while not compromising on safety. Overall, patient satisfaction was achieved more frequently in those subjects who utilized the combination therapy," concluded the authors.


    To read the full study log on to https://doi.org/10.1016/j.jaad.2019.05.063

    combination therapydoxycyclinefacial burningfacial stingingflushingIvermectinivermectin creamJournal of the American Academy of Dermatologymodified release capsulesmonotherapyoraloral agentspatient satisfactionrednessrosaceaskinskin clearanceskin conditionskin creamskin disordertopicaltopical agentstreatment

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok